LUMO logo

Lumos Pharma (LUMO) Selling, General & Administrative Expenses

Annual SG&A

$16.57 M
+$863.00 K+5.49%

31 December 2023

3-Year Change

+8.08%
LUMO annual selling, general & administrative expenses is up +8.08% over the past 3 years

All-time High

$33.23 M
LUMO annual selling, general & administrative expenses is currently -50.13% below its historical high of $33.23 million
Annual Total Expenses$38.66 M
LUMO annual total expenses is $38.66 million
Annual Operating Expenses$38.66 M
LUMO annual total operating expenses is $38.66 million
Annual Revenue$2.05 M
LUMO annual revenue is $2.05 million
Annual Net Income-$34.03 M
LUMO annual net profit is -$34.03 million

LUMO Selling, General & Administrative Expenses Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly SG&A

$4.21 M
+$531.00 K+14.42%

30 September 2024

1-Year Change

+0.96%
LUMO quarterly selling, general & administrative expenses is up +0.96% year-on-year

3-Year Change

+22.9%
LUMO quarterly selling, general & administrative expenses is up +22.9% over the past 3 years

All-time High

$9.16 M
LUMO quarterly selling, general & administrative expenses is currently -54.03% below its historical high of $9.16 million
Quarterly Total Expenses$8.37 M
LUMO quarterly total expenses is $8.37 million
Quarterly Operating Expenses$8.37 M
LUMO quarterly total operating expenses is $8.37 million
Quarterly Revenue$726.00 K
LUMO quarterly revenue is $726.00 thousand
Quarterly Net Income-$7.47 M
LUMO quarterly net profit is -$7.47 million

LUMO Quarterly SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM SG&A

-$699.96 M
-$34.92 M-5.25%

30 September 2024

1-Year Change

-4324.52%
LUMO TTM selling, general & administrative expenses is down -4324.52% year-on-year

3-Year Change

-4665.65%
LUMO TTM selling, general & administrative expenses is down -4665.65% over the past 3 years

All-time High

$33.73 M
LUMO TTM selling, general & administrative expenses is currently -2175.49% below its historical high of $33.73 million
Annual Total Expenses$38.66 M
LUMO annual total expenses is $38.66 million
Annual Operating Expenses$38.66 M
LUMO annual total operating expenses is $38.66 million
TTM Revenue$2.21 M
LUMO TTM revenue is $2.21 million
TTM Net Income-$34.92 M
LUMO TTM net profit is -$34.92 million

LUMO TTM SG&A Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

LUMO Selling, General & Administrative Expenses Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-+1.0%-4324.5%
3 y3 years+8.1%+22.9%-4665.6%
5 y5 years+299.5%+236.0%-10000.0%

LUMO Selling, General & Administrative Expenses High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years
5 y5 years
alltimeall time-50.1%-54.0%-2175.5%

Lumos Pharma Selling, General & Administrative Expenses History

DateAnnualQuarterlyTTM
Sept 2024
-
$4.21 M(+14.4%)
$15.85 M(+2.1%)
June 2024
-
$3.68 M(-2.6%)
$15.53 M(-2.9%)
Mar 2024
-
$3.78 M(-9.4%)
$15.99 M(-3.5%)
Dec 2023
$16.57 M(+5.5%)
$4.17 M(+7.2%)
$16.57 M(-1.8%)
Sept 2023
-
$3.89 M(-6.1%)
$16.88 M(-0.1%)
June 2023
-
$4.15 M(-4.8%)
$16.91 M(-15.7%)
Mar 2023
-
$4.36 M(-2.9%)
$20.06 M(+3.8%)
Dec 2022
$15.71 M(+2.4%)
$4.49 M(+14.5%)
$19.33 M(+5.8%)
Sept 2022
-
$3.92 M(-46.4%)
$18.27 M(+3.0%)
June 2022
-
$7.30 M(+101.7%)
$17.74 M(+18.3%)
Mar 2022
-
$3.62 M(+5.6%)
$14.99 M(-2.2%)
Dec 2021
$15.33 M(-11.2%)
$3.43 M(+1.3%)
$15.33 M(-7.3%)
Sept 2021
-
$3.38 M(-25.8%)
$16.53 M(-9.7%)
June 2021
-
$4.56 M(+15.3%)
$18.30 M(+2.3%)
Mar 2021
-
$3.96 M(-14.6%)
$17.89 M(+3.6%)
Dec 2020
$17.27 M(+316.3%)
$4.63 M(-10.2%)
$17.27 M(+24.3%)
Sept 2020
-
$5.16 M(+24.3%)
$13.89 M(+35.8%)
June 2020
-
$4.15 M(+24.5%)
$10.23 M(+50.5%)
Mar 2020
-
$3.33 M(+165.6%)
$6.79 M(+63.9%)
Dec 2019
$4.15 M(-85.8%)
$1.25 M(-16.2%)
$4.15 M(-50.2%)
Sept 2019
-
$1.50 M(+109.5%)
$8.32 M(-42.3%)
June 2019
-
$714.00 K(+4.5%)
$14.41 M(-33.3%)
Mar 2019
-
$683.00 K(-87.4%)
$21.61 M(-26.0%)
Dec 2018
$29.22 M(-7.9%)
$5.43 M(-28.5%)
$29.22 M(-4.1%)
Sept 2018
-
$7.59 M(-4.1%)
$30.48 M(-1.0%)
June 2018
-
$7.91 M(-4.6%)
$30.80 M(-3.1%)
Mar 2018
-
$8.29 M(+24.0%)
$31.78 M(+0.2%)
Dec 2017
$31.73 M
$6.69 M(-15.4%)
$31.73 M(-1.5%)
Sept 2017
-
$7.91 M(-11.1%)
$32.22 M(+0.5%)
DateAnnualQuarterlyTTM
June 2017
-
$8.90 M(+8.1%)
$32.06 M(-0.7%)
Mar 2017
-
$8.23 M(+14.6%)
$32.30 M(-2.8%)
Dec 2016
$33.23 M(+8.3%)
$7.18 M(-7.3%)
$33.23 M(-1.5%)
Sept 2016
-
$7.75 M(-15.1%)
$33.73 M(+1.1%)
June 2016
-
$9.13 M(-0.4%)
$33.36 M(+5.9%)
Mar 2016
-
$9.16 M(+19.3%)
$31.49 M(+2.6%)
Dec 2015
$30.69 M(+58.8%)
$7.68 M(+4.0%)
$30.69 M(-1.9%)
Sept 2015
-
$7.38 M(+1.8%)
$31.29 M(+8.5%)
June 2015
-
$7.26 M(-13.3%)
$28.84 M(+18.0%)
Mar 2015
-
$8.37 M(+1.0%)
$24.44 M(+26.5%)
Dec 2014
$19.33 M(+103.0%)
$8.28 M(+68.0%)
$19.33 M(+37.6%)
Sept 2014
-
$4.93 M(+72.2%)
$14.04 M(+23.5%)
June 2014
-
$2.86 M(-11.9%)
$11.37 M(+5.6%)
Mar 2014
-
$3.25 M(+8.4%)
$10.77 M(+13.1%)
Dec 2013
$9.52 M(+33.9%)
$3.00 M(+32.9%)
$9.52 M(+10.4%)
Sept 2013
-
$2.26 M(-0.3%)
$8.63 M(+11.1%)
June 2013
-
$2.26 M(+13.1%)
$7.76 M(+1.5%)
Mar 2013
-
$2.00 M(-4.9%)
$7.65 M(+7.6%)
Dec 2012
$7.11 M(+25.2%)
$2.10 M(+50.6%)
$7.11 M(-0.3%)
Sept 2012
-
$1.40 M(-35.1%)
$7.13 M(+4.3%)
June 2012
-
$2.15 M(+47.5%)
$6.84 M(+17.4%)
Mar 2012
-
$1.46 M(-31.4%)
$5.82 M(+2.5%)
Dec 2011
$5.68 M(-6.5%)
$2.13 M(+93.1%)
$5.68 M(-2.2%)
Sept 2011
-
$1.10 M(-3.1%)
$5.80 M(-7.0%)
June 2011
-
$1.14 M(-13.7%)
$6.24 M(+22.2%)
Mar 2011
-
$1.32 M(-41.5%)
$5.11 M(+34.7%)
Dec 2010
$6.07 M(+63.9%)
$2.25 M(+46.3%)
$3.79 M(+176.8%)
Sept 2010
-
$1.54 M(-1005.3%)
$1.37 M(-905.3%)
Dec 2009
$3.71 M(-19.4%)
-$170.00 K
-$170.00 K
Dec 2008
$4.60 M
-
-

FAQ

  • What is Lumos Pharma annual selling, general & administrative expenses?
  • What is the all time high annual SG&A for Lumos Pharma?
  • What is Lumos Pharma quarterly selling, general & administrative expenses?
  • What is the all time high quarterly SG&A for Lumos Pharma?
  • What is Lumos Pharma quarterly SG&A year-on-year change?
  • What is Lumos Pharma TTM selling, general & administrative expenses?
  • What is the all time high TTM SG&A for Lumos Pharma?
  • What is Lumos Pharma TTM SG&A year-on-year change?

What is Lumos Pharma annual selling, general & administrative expenses?

The current annual SG&A of LUMO is $16.57 M

What is the all time high annual SG&A for Lumos Pharma?

Lumos Pharma all-time high annual selling, general & administrative expenses is $33.23 M

What is Lumos Pharma quarterly selling, general & administrative expenses?

The current quarterly SG&A of LUMO is $4.21 M

What is the all time high quarterly SG&A for Lumos Pharma?

Lumos Pharma all-time high quarterly selling, general & administrative expenses is $9.16 M

What is Lumos Pharma quarterly SG&A year-on-year change?

Over the past year, LUMO quarterly selling, general & administrative expenses has changed by +$40.00 K (+0.96%)

What is Lumos Pharma TTM selling, general & administrative expenses?

The current TTM SG&A of LUMO is -$699.96 M

What is the all time high TTM SG&A for Lumos Pharma?

Lumos Pharma all-time high TTM selling, general & administrative expenses is $33.73 M

What is Lumos Pharma TTM SG&A year-on-year change?

Over the past year, LUMO TTM selling, general & administrative expenses has changed by -$716.53 M (-4324.52%)